Cigna said it isn't buying Humana, per a Wall Street Journal report, which noted that Cigna spoke up because of ongoing ...
Cigna's bold move to halt merger talks with Humana sends shockwaves through the market, while stock buybacks ramp up.
Analyst Steve Baxter of Wells Fargo maintained a Hold rating on Cigna (CI – Research Report), retaining the price target of $355.00.
The stock is up more than 40% since Nov. 5, topping $1 trillion in market value. Elon Musk had previously contributed at ...
The show starts by highlighting notable company updates and stock reactions for several top stocks, including Cigna (CI), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback